Synthetic Biotechnology is an innovative field that combines principles of biology and engineering to design and construct new biological entities or redesign existing ones for specific purposes. It involves the application of engineering principles to create synthetic biological systems with enhanced functionalities.
Researchers in Synthetic Biotechnology use genetic engineering, molecular biology, and computational methods to construct artificial biological components, such as genes and proteins, and assemble them into functional systems. These metabolic engineering systems can be used for a range of applications, including the production of biofuels, pharmaceuticals, and biomaterials. This field aims to create biological systems with novel properties that go beyond what is found in nature. Ethical considerations and safety precautions are paramount in Synthetic Biotechnology, as it involves the intentional modification of living organisms. Ongoing advancements in this field hold promise for addressing challenges in medicine, energy production. Successful translation relies on collaborative efforts between scientists, clinicians, and industry professionals, accelerating the transformation of research discoveries into tangible benefits for patients.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia